Fibrolamellar carcinoma of the liver: Composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules

Hepatology

Volumn 24, Issue 5, 1996, Pages 1128-1136

  Scoazec, Jean Yves ^a   Flejou, Jean François ^a,b   D'Errico, Antonia ^c   Fiorentino, Michelangelo ^c   Zamparelli, Alessandra ^a,c   Bringuier, Annie France ^a   Feldmann, Gérard ^a   Grigioni, Walter F ^c  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; TENASCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LIVER CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029909951     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008903387     Document Type: Article

References (49)

1. Craig JR, Peters RL, Edmonson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980;46:372-379.
2. Bearman MM, Libbey P, Foster JH. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma - an atypical variant with a favorable prognosis. Cancer 1980;46:1448-1455.
3. Hodgson HJF. Fibrolamellar carcinoma of the liver. J Hepatol 1987;5:241-247.
4. Caballero T, Aneiros J, Lopez-Caballero J, Gomez-Morales M, Nogales F. Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultrastructural study. Histopathology 1985;9:445-456.
5. Teitelbaum DH, Tuttle S, Carey LC, Clausen ICP. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg 1986;202:36-41.
6. Wetzel WJ, Costin JL, Petrino RL. Fibrolamellar carcinoma: distinctive clinical and morphologic variant of hepatoma. South Med J 1983;76:796-798.
7. Farhi DC, Shikes RH, Silverberg SG. Ultrastructure of fibrolamellar oncocytic hepatoma. Cancer 1982;50:702-709.
8. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988;19:784-794.
9. Nagorney DM, Adson MA, Weiland LH, Knight CD Jr, Smalley SR, Zinsmeister AR. Fibrolamellar hepatoma. Am J Surg 1985;149:113-119.
10. Soreide O, Czerniak A, Bradpiece H, Bloom S, Blumgart L. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg 1986;151:518-523.
11. Erickson HP, Bourdon MA. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 1989;5:71-101.
12. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983;49:140-147.
13. Martinez-Hernandez A, Amenta PS. The basement membrane in pathology. Lab Invest 1983;48:656-677.
14. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4-17.
15. Tarin D, Matsumura Y. Recent advances in the study of tumor invasion and metastasis. J Clin Pathol 1994;47:385-390.
16. Birchmeier W, Behrens J. Cadherin expression: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994;1198:11-26.
17. Edmonson HA. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, section VII, fascicle 25. Washington: Armed Forces Institute of Pathology, 1958.
18. Palmer EL, Rüegg C, Ferrando R, Pytela R, Sheppard D. Sequence and distribution of the integrin α9 subunit, a novel partner of b1 that is widely distributed in epithelia and muscle. J Cell Biol 1993;123:1289-1297.
19. Nagafuchi A, Tsukita S. The loss of the expression of α-catenin, the 102 kD cadherin associated protein, in central nervous tissues during development. Development, Growth and Differentiation 1994;36:59-71.
20. Graham RC Jr, Karnovsky MJ. The early stages of absorption of horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem 1966;14:291-298.
21. Zhao M, Laissue JA, Zimmermann A. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Histol Histopathol 1996;11:323-333.
22. Oka H, Shiozaki H, Inoue M, Kobayashi K, Tahara H, Kobayashi T, Takatsuka Y, et al. Expression of E-cadherin adhesion molecules in human breast cancer tissues and its relationships to metastasis. Cancer Res 1993; 53:1696-1701.
23. Ocklind G, Talts J, Fässler R, Mattsson A, Ekblom P. Expression of tenascin in developing and adult mouse lymphoid organs. J Histochem Cytochem 1993;41:1163-1169.
24. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990;10:1-10.
25. Scoazec J-Y, Fléjou J-F, D'Errico A, Couvelard A, Kozyraki R, Fiorentino M, Grigioni WF, et al. Focal nodular hyperplasia of the liver: composition of the extracellular matrix and expression of cell-cell and cell-adhesion molecules. Hum Pathol 1995;26:1114-1125.
26. Kozyraki R, Scoazec J-Y, Fléjou J-F, D'Errico A, Bedossa P, Terris B, Fiorentino M, et al. Expression of cadherins and α-catenin in primary epithelial tumors of the liver. Gastroenterology 1996;110:1137-1149.
27. Geerts A, Wisse E. Tenascin expression in human chronic liver disease and in hepatocellular carcinoma. Liver 1992;12:10-16.
28. Grigioni WF, D'Errico A, Mancini AM, Biagini G, Gozzetti G, Mazziotti A, Garbisa S. Hepatocellular carcinoma: expression of basement membrane glycoproteins. An immunohistochemical approach. J Pathol 1987;152:325-332.
29. Grigioni WF, Garbisa S, D'Errico A, Baccarini P, Stetler-Stevenson WG, Liotta LA, Mancini AM. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 1991; 138:647-654.
30. Donato MF, Colombo M, Matarazzo M, Paronetto F. Distribution of basement membrane components in human hepatocellular carcinoma. Cancer 1989;63:272-279.
31. Vecchio FM, Fabiano A, Ghirlanda G, Manna R, Massi G. Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change. Am J Clin Pathol 1984;81:521-526.
32. Saul SH, Titelbaum DS, Gansler TS, Varello M, Burke DR, Atkinson BF, Rosato EF. The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia. Cancer 1987;60:3049-3055.
33. Thung SN, Gerber MA. Development of malignancy in benign tumors of the liver. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, pathology, and treatment of hepatocellular carcinoma in North America. Houston: Gulf Publishing Company, 1991:209-215.
34. Volpes R, van den Oord JJ, Desmet VJ. Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology 1991;101:200-206.
35. Volpes R, van den Oord JJ, Desmet VJ. Integrins as differential cell lineage markers in primary liver tumors. Am J Pathol 1993;142:1483-1492.
36. Collier NA, Bloom SR, Hodgson HJF, Weinbren K, Lee YC, Blumgart LH. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1984; i:538-540.
37. Lee YC, Bacarese-Hamilton AJ, Wood SM, Blumgart LH, Bloom SR. Chromatographic characterization of neurotensin-like immunoreactivity in plasma and tissue extracts from hepatoma patients. Clin Chim Acta 1985; 149:29-36.
38. Wang J, Dhillon AP, Sankey EA, Wightman AK, Lewin JF, Scheuer PJ. 'Neuroendocrine' differentiation in primary neoplasms of the liver. J Pathol 1991;163:61-67.
39. Bosman FT. Endocrine cells in non-endocrine tumours. J Pathol 1989;159: 181-182.
40. Sarsfield P, Anthony PP. Small cell undifferentiated ('neuroendocrine') carcinoma of the colon. Histopathology 1990;16:357-363.
41. di Sant'Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992;23:287-296.
42. Bang Y-J, Pirnia F, Fang W-G. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A 1994;91:5330-5334.
43. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-811.
44. Shimoyama Y, Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 1991;57:131-135.
45. x) is responsible for distinct adhesive properties of carcinoma cells. Cell 1989;57:59-69.
46. v gene expression in human melanoma tumorigenicity. J Clin Invest 1992;89:2018-2022.
47. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;240:1053-1058.
48. Orsatti G, Greenberg PD, Rolfes DB, Ishak KG, Paronetto F. DNA ploidy of fibrolamellar hepatocellular carcinoma by image analysis. Hum Pathol 1994;25:936-939.
49. Altmann HW. Some histological remarks on the fibrolamellar carcinoma of the liver. Pathol Res Pract 1990;186:63-69.